sinc
anthrax
letter
attack
octob
us
feder
govern
place
premium
homeland
secur
research
develop
consid
key
compon
integr
unifi
biodef
strategi
fiscal
year
presid
bush
propos
billion
budget
biodef
research
administ
primarili
nation
institut
allergi
infecti
diseas
niaid
nation
institut
health
nih
summar
niaid
web
site
see
onlin
link
box
propos
new
biodef
research
agenda
broadli
focu
studi
categori
categori
b
categori
c
bioterror
agent
inform
see
onlin
link
box
potenti
bioterror
agent
share
sever
featur
includ
high
morbid
mortal
associ
infect
high
likelihood
persontoperson
spread
abil
made
weapon
spread
aerosol
food
water
suppli
potenti
caus
widespread
panic
public
releas
environ
goal
acceler
research
develop
agenda
understand
better
molecular
mechan
respons
pathogen
transmiss
virul
invas
develop
new
anim
model
diseas
use
studi
potenti
bioterror
agent
elucid
host
respons
microb
understand
better
complex
paramet
innat
acquir
immun
might
manipul
exposur
potenti
bioterror
agent
develop
new
vaccin
antimicrobi
antivir
therapeut
diagnost
tool
threaten
diseas
smallpox
anthrax
plagu
develop
research
resourc
laboratori
contain
facil
allow
work
categori
ac
agent
possibl
present
ultim
expect
new
research
activ
increas
level
prepared
might
better
respond
protect
world
popul
bioterror
much
need
done
realiz
ambiti
goal
niaid
strateg
plan
biodefens
researchthi
includ
expand
research
portfolio
develop
new
tool
reagent
also
creation
new
research
facil
recruit
new
investig
area
infecti
diseas
research
septemb
us
depart
health
human
servic
announc
creation
eight
region
center
excel
biodefens
emerg
diseas
rce
aim
rce
bring
togeth
investig
sever
disciplin
public
privat
institut
tackl
compel
research
question
relev
bioterror
agent
particularli
anthrax
smallpox
larg
comprehens
programm
inform
rce
see
onlin
link
box
collect
set
new
research
agenda
apart
previou
effort
studi
infecti
diseas
agent
inform
deriv
would
avail
scientist
time
could
think
new
postgenom
era
microb
biolog
ref
genom
proteom
bioinformat
consid
key
enabl
technolog
develop
new
method
deal
potenti
bioterror
agent
emerg
infecti
diseas
review
summar
statu
pathogen
genom
sequenc
analysi
present
discuss
approach
might
best
appli
biodef
prepared
intent
spread
diseas
war
biowarfar
long
histori
date
back
ancient
greek
roman
box
bioterror
contrast
much
shorter
histori
recent
event
particular
anthrax
letter
attack
expos
vulner
area
bioprepared
natur
deliber
outbreak
infecti
diseas
dearth
investig
studi
biowarfar
pathogen
special
facil
carri
research
rudimentari
understand
mechan
pathogenesi
agent
also
lack
rapid
precis
diagnost
assay
identifi
speci
deliber
releas
microbi
pathogen
done
part
without
notic
signific
number
symptomat
patient
appear
expect
rel
short
period
time
expand
research
activ
must
achiev
sever
key
object
provid
immedi
benefit
public
health
arena
also
anticip
one
posit
spinoff
new
bioterror
research
agenda
certainli
better
understand
common
natur
occur
infecti
agent
import
goal
least
vulner
emerg
infecti
diseas
deliber
attack
recent
sever
acut
respiratori
syndrom
sar
epidem
month
kill
peopl
countri
illustr
devast
new
diseas
quickli
spread
around
world
inform
sar
see
onlin
link
box
barri
bloom
present
director
harvard
school
public
health
summar
potenti
genomicsbas
approach
expand
understand
biolog
pathogen
ref
public
second
complet
microbi
genom
sequenc
state
power
cost
effect
modern
genom
sequenc
technolog
mean
complet
genom
sequenc
major
bacteri
parasit
pathogen
could
avail
within
year
million
could
buy
sequenc
everi
virul
determin
everi
protein
antigen
everi
drug
target
would
repres
pathogen
onetim
invest
biolog
warfar
began
ancient
greek
roman
use
toxic
plant
human
anim
corps
poison
drinkingwat
well
recent
fourteenth
centuri
tartar
catapult
bodi
plagu
victim
citi
wall
infect
genoes
inhabit
caffa
trade
centr
black
sea
genoes
took
boat
escap
spread
black
death
along
ship
rout
throughout
europ
year
plagu
kill
approxim
onethird
europ
popul
seventeenth
eighteenth
centuri
saw
french
british
soldier
intent
infect
nativ
american
european
diseas
exampl
sir
jeffrey
amherst
order
smallpox
spread
way
inocul
indian
mean
blanket
extirp
execr
first
world
war
germani
plan
conduct
covert
oper
unit
state
intent
infect
hors
cattl
destin
servic
europ
glander
anthrax
second
world
war
bioweapon
programm
initi
everi
major
particip
countri
japanes
militari
practic
biowarfar
larg
scale
chines
manchuria
infect
popul
variou
diseas
agent
includ
anthrax
cholera
plagu
cold
war
brought
even
greater
escal
bioweapon
programm
unit
state
soviet
union
presid
nixon
termin
offens
bioweapon
programm
unit
state
order
stockpil
weapon
destroy
unit
state
nation
sign
biolog
toxin
weapon
convent
first
treati
ban
entir
class
weapon
bioweapon
work
continu
soviet
union
outbreak
inhal
anthrax
sverdlosk
link
secret
weapon
work
nearbi
laboratori
soviet
defector
confirm
soviet
union
work
creat
genet
engin
strain
pathogen
resist
antibiot
vaccin
breakup
soviet
union
mid
mani
soviet
scientist
carri
work
disappear
resurfac
countri
iraq
launch
bioweapon
programm
around
time
bioterror
much
shorter
histori
follow
guru
bhagwan
shree
rajneesh
deliber
contamin
salad
bar
throughout
one
counti
oregon
usa
salmonella
goal
sicken
suffici
number
peopl
prevent
vote
elect
case
food
poison
report
took
year
discov
sourc
contamin
aum
shinrikyo
cult
releas
sarin
ga
subway
tokyo
japan
kill
peopl
injur
thousand
cult
tri
spray
botulinum
toxin
anthrax
kameido
citi
near
tokyo
success
recent
octob
anthrax
attack
carri
unit
state
use
us
postal
servic
deliveri
vehicl
result
death
case
anthrax
infect
shut
postal
servic
us
congression
offic
time
perpetr
crime
still
larg
third
highest
prioriti
agent
includ
emerg
pathogen
could
engin
mass
dissemin
futur
avail
eas
product
dissemin
potenti
high
morbid
mortal
rate
major
health
impact
laboratori
facil
work
biolog
agent
might
caus
seriou
potenti
lethal
diseas
result
exposur
inhal
rout
laboratori
facil
work
danger
exot
biolog
agent
pose
high
individu
risk
aerosoltransmit
laboratori
infect
lifethreaten
diseas
state
adequ
prepar
case
bioterror
attack
allow
rapid
effici
respons
contain
spread
agent
minim
morbid
mortal
minim
disrupt
public
infrastructur
glander
contagi
diseas
hors
mule
donkey
caus
bacterium
burkholderia
mallei
also
transmit
human
come
contact
infect
anim
compar
genom
genom
sequenc
data
provid
power
new
start
point
followup
investig
biolog
microbi
pathogen
power
compar
genom
silico
possibl
glean
insight
new
virul
gene
molecular
basi
evolut
pathogen
divers
within
close
relat
isol
formul
hypothes
test
experiment
exampl
sequenc
b
anthraci
genom
result
identif
sever
new
put
virul
gene
recent
shown
encod
function
toxin
sever
b
anthraci
gene
identifi
encod
protein
relat
protein
respons
virul
close
relat
bacillu
speci
infect
insect
clear
whether
gene
role
b
anthraci
speci
nonetheless
obviou
candid
futur
experiment
studi
import
studi
overemphas
bioinformat
approach
alon
suffici
unequivoc
predict
protein
function
identif
new
virul
pathogen
gene
bioterror
pathogen
provid
new
insight
agent
caus
diseas
also
potenti
provid
new
target
antimicrobi
vaccin
develop
comparison
recent
complet
genom
sequenc
intracellular
pathogen
potenti
bioterror
agent
brucella
sui
brucella
melitensi
defin
finit
set
differ
could
respons
differ
virul
host
prefer
present
close
relat
organ
analysi
b
sui
genom
also
reveal
transport
metabol
abil
similar
seen
soilplantassoci
bacteria
similar
also
evid
extens
gene
synteni
observ
b
sui
chromosom
genom
plant
symbiont
mesorhizobium
loti
result
illustr
advantag
come
take
broad
view
studi
pathogenesi
new
data
biolog
one
pathogen
could
directli
applic
studi
might
seem
unrel
pathogen
silico
approach
reveal
molecular
differ
distinguish
relat
speci
identifi
potenti
virul
gene
alon
suffici
uncov
complex
interact
pathogen
host
howev
avail
largescal
approach
transcriptom
analysi
begin
impact
infecti
diseas
research
allow
investig
move
beyond
studi
singl
gene
probe
global
chang
rna
express
although
technolog
avail
small
number
laboratori
year
ago
wide
avail
use
studi
gene
express
pathogen
host
differ
stage
infect
one
import
advantag
type
approach
allow
studi
known
gene
new
gene
unknown
function
medic
facil
even
earliest
symptom
associ
infect
biowarfar
pathogen
nonspecif
easili
masquerad
someth
less
seriou
attack
detect
panic
gener
popul
could
overwhelm
public
healthcar
system
make
difficult
identifi
treat
individu
actual
expos
although
recommend
administ
antimicrobi
therapi
bioterror
attack
categori
agent
propos
work
group
civilian
biodefens
mani
case
limit
data
avail
efficaci
dose
regimen
instanc
three
eight
week
antibiot
therapi
recommend
howev
one
danger
inher
prolong
cours
treatment
noncompli
emerg
antibioticresist
pathogen
continu
emerg
antibioticresist
strain
common
pathogen
well
clear
would
greatli
benefit
expand
arsen
new
antibiot
anoth
altern
combat
infecti
diseas
develop
new
better
vaccin
confer
longterm
immun
could
use
prophylact
bioterror
attack
new
gener
vaccin
must
abl
protect
group
civilian
includ
larg
number
immunocompromis
patient
present
popul
recent
report
unexpect
cardiac
problem
includ
two
death
occur
vaccin
firstrespond
present
smallpox
vaccin
numer
report
advers
reaction
present
vaccin
anthrax
provid
exampl
much
extra
work
need
final
urgent
need
understand
better
genet
variat
among
global
distribut
bacteri
speci
strain
microbi
genom
dynam
entiti
shape
numer
forc
includ
gene
duplic
gene
acquisit
later
gene
transfer
influenc
evolut
microbi
speci
plastic
microbi
genom
import
implic
epidemiolog
studi
spread
antibiot
resist
pathogen
microbi
forens
develop
new
therapeut
vaccin
despit
fact
field
microbi
genom
still
rel
young
tremend
progress
made
short
amount
time
essenti
princip
human
bacteri
pathogen
includ
mani
center
diseas
control
prevent
cdc
categori
ac
list
sequenc
sequenc
data
associ
genom
annot
effort
public
domain
see
tigr
microbi
databas
onlin
link
box
sever
case
sequenc
data
one
repres
speci
avail
exampl
escherichia
coli
staphylococcu
aureu
mycobacterium
tuberculosi
bacillu
anthraci
helicobact
pylori
chlamydia
pneumonia
tabl
prove
extrem
use
provid
new
insight
genet
variabl
present
among
strain
synteni
conserv
gene
order
chromosom
conserv
wide
evolutionari
distanc
human
cell
initi
interact
epitheli
cell
respiratori
tract
later
interact
endotheli
cell
bloodbrain
barrier
differenti
regul
gene
includ
encod
membran
transport
transcript
factor
gener
metabol
pathway
sever
hypothet
recent
studi
neisseria
meningitidi
caus
agent
septicaemia
meningococc
mening
provid
excel
exampl
use
transcriptom
analysi
studi
show
distinct
set
gene
differenti
regul
two
key
step
meningococc
infect
potenti
vaccin
candid
although
proteom
approach
still
limit
factor
sensit
scalabl
particularli
well
suit
identifi
protein
local
pathogen
cytoplasm
versu
membran
versu
secret
protein
might
key
step
toward
understand
pathogenesi
numer
potenti
bioterror
agent
particular
interest
regard
studi
bioterror
pathogen
result
recent
studi
proteom
analysi
use
studi
spore
coat
protein
b
anthraci
relat
nonpathogen
speci
bacillu
subtili
respons
extern
stress
bacilli
form
spore
protein
obviou
candid
studi
turn
could
lead
new
approach
prevent
diseas
caus
n
meningitidi
studi
like
identifi
suit
gene
differenti
express
differ
stage
infect
could
similarli
lead
new
biodef
strategi
appli
bioterror
agent
b
anthraci
parallel
transcriptom
studi
highli
sensit
twodimension
gel
electrophoresi
protein
identif
mass
spectrometri
use
explor
proteom
sever
pathogen
analys
use
identifi
differ
protein
express
virul
avirul
strain
mass
spectrometri
analysi
use
analyt
instrument
provid
accur
inform
molecular
mass
structur
complex
molecul
techniqu
identifi
quantifi
extrem
small
amount
peptid
massfrag
spectrum
avail
compar
genom
hybrid
technolog
rapidli
appli
studi
larg
number
isol
identifi
subset
gene
might
respons
phenotyp
differ
pathogenesi
virul
advanc
understand
microbi
evolut
genom
heterogen
howev
one
limit
microarraybas
analysi
gene
content
array
provid
inform
gene
repres
array
given
genet
divers
observ
speci
bacteria
differ
gene
content
avirul
e
coli
strain
enteropathogen
e
coli
strain
caution
necessari
interpret
compar
genom
hybrid
data
absenc
comprehens
inform
strain
variabl
one
excit
applic
compar
genom
hybrid
approach
might
come
develop
rapid
method
detect
biolog
agent
even
genet
engin
unreason
contempl
fabric
dna
chip
contain
predict
code
sequenc
numer
isol
import
human
anim
plant
pathogen
first
step
develop
new
detect
technolog
readout
detector
could
provid
inform
full
genet
complement
bioterror
agent
even
contain
gene
plasmid
speci
unusu
properti
relat
virul
antibioticresist
synthet
organ
built
compon
gene
abil
quickli
identifi
character
potenti
bioterror
agent
singl
assay
would
greatli
reduc
delay
inher
present
method
detect
progress
toward
goal
begun
develop
multipathogen
identif
microarray
mpid
use
identifi
pathogen
prokaryot
bacteria
virus
high
degre
specif
oligonucleotid
array
detect
close
relat
orthopox
virus
includ
variola
caus
agent
smallpox
alarm
increas
resist
multipl
antibiot
among
pathogen
aureu
streptococcu
pneumonia
enterococcu
faecali
tuberculosi
commun
hospit
set
past
year
quit
recent
primari
approach
antibiot
develop
within
pharmaceut
industri
make
increment
improv
exist
antibiot
class
stay
one
step
ahead
resist
microb
present
antibiot
target
three
cellular
process
bacteri
cell
dnarna
synthesi
protein
synthesi
cellwal
synthesi
reason
three
pathway
make
excel
target
antimicrobi
compound
repres
essenti
cellular
function
analog
protein
essenti
cell
viabil
becom
possibl
target
develop
entir
new
class
antibiot
allow
persist
environ
extrem
temperatur
dessic
time
case
b
anthraci
interact
spore
host
essenti
infect
proteom
analysi
uncov
set
conserv
spore
coat
protein
set
new
spore
coat
protein
uniqu
speci
bacillu
identif
uniqu
spore
coat
protein
b
anthraci
could
acceler
effort
develop
new
method
detect
organ
environ
well
provid
new
target
interact
pathogen
host
macrophag
might
disrupt
anoth
import
research
area
biodef
studi
host
respons
trigger
infect
potenti
bioterror
pathogen
avail
human
genom
sequenc
human
dna
array
mean
type
studi
requir
possibl
exampl
one
recent
studi
found
mark
differ
geneexpress
profil
gastric
epitheli
cell
expos
strain
h
pylori
gastric
pathogen
pathogen
island
compar
cell
expos
strain
lack
island
studi
highlight
gene
might
involv
observ
differ
diseas
outcom
infect
anoth
studi
use
sever
approach
includ
microarray
analysi
identifi
gene
murin
macrophag
upregul
respons
infect
cell
yersinia
pesti
caus
agent
plagu
sever
gene
previous
shown
involv
apoptosi
data
consist
fact
mani
pathogen
pesti
known
circumv
immun
respons
host
interf
normal
function
circul
macrophag
case
trigger
cell
death
indic
possibl
intervent
strategi
might
pursu
develop
new
therapeut
treat
diseas
dna
array
also
use
investig
respons
human
peripher
blood
mononuclear
cell
pbmc
exposur
variou
bacteri
pathogen
cell
play
vital
surveil
role
detect
exposur
infecti
agent
consid
immun
system
canari
coal
mine
exposur
pbcm
numer
donor
mani
gramposit
gramneg
bacteri
pathogen
show
consist
programm
gene
express
character
upregul
mani
cytokin
chemokin
result
could
provid
basi
new
diagnost
test
pathogen
microb
perhap
even
overt
symptom
develop
diagnost
test
could
extrem
import
biolog
earli
warn
system
biodef
purpos
dna
microarray
technolog
also
use
assess
molecular
differ
close
relat
pathogen
strain
complet
genom
sequenc
pathogen
island
genet
element
within
genom
organ
respons
capac
caus
diseas
pathogen
virul
organ
modul
gene
harbour
island
includ
aminoacyltrna
synthetas
polypeptid
deformylas
fattyacid
biosynthesi
dna
replic
protein
secret
cell
divis
peptidoglycan
biosynthesi
cell
signal
aminoacid
biosynthesi
although
pro
con
develop
new
broadspectrum
antibiot
versu
antibiot
highli
specif
particular
infecti
agent
seem
might
possibl
achiev
success
front
use
genom
inform
drugdiscoveri
process
genomicsbas
approach
also
greatli
acceler
search
new
vaccin
candid
particularli
pathogen
induc
antibodi
format
human
andor
experiment
anim
describ
transcriptom
proteom
analys
variou
pathogen
identifi
subset
gene
import
infect
therefor
possibl
target
vaccin
develop
altern
strategi
known
revers
vaccinolog
use
bioinformat
method
identifi
potenti
cellsurfac
protein
follow
largescal
express
evalu
candid
antigen
anim
model
far
approach
success
appli
n
meningitidi
pneumonia
new
n
meningitidi
vaccin
candid
discov
revers
vaccinolog
enter
phase
clinic
trial
r
rappuoli
person
commun
fig
also
use
immun
sera
togeth
cellsurfac
display
aureu
peptid
identifi
sever
potenti
vaccin
candid
patient
infect
avail
pathogen
genom
sequenc
data
catalys
research
identif
new
target
antimicrobi
compound
provid
complet
catalogu
gene
across
wide
rang
organ
compar
variou
level
four
attribut
ideal
antimicrobi
target
essenti
viabil
microbi
pathogen
absent
significantli
differ
human
host
paramet
much
easier
assess
given
avail
human
genom
sequenc
conserv
across
appropri
rang
organ
express
relev
infecti
process
silico
approach
compar
pathogen
organ
nonpathogen
rel
provid
firstpass
list
potenti
gene
requir
colon
invas
virul
method
transposon
mutagenesi
vivo
express
technolog
ivet
exampl
allow
largescal
screen
essenti
protein
vitro
vivo
even
biolog
function
protein
known
new
target
identifi
screen
programm
turn
use
highthroughput
screen
assay
combinatori
chemistri
librari
identifi
potenti
smallmolecul
inhibitor
protein
function
kind
approach
make
full
use
inform
genom
databas
allow
assay
system
drive
identif
new
target
first
step
process
complet
genom
sequenc
pathogen
interest
case
menb
took
approxim
month
time
undertaken
today
complet
genom
sequenc
pathogen
obtain
matter
day
week
sever
algorithm
use
identifi
put
cellsurfac
secret
protein
could
potenti
elicit
antibodi
respons
human
host
menb
potenti
vaccin
candid
identifi
bioinformat
approach
next
step
process
produc
recombin
protein
escherichia
coli
approxim
protein
express
high
level
purifi
use
immunogen
mice
immun
sera
collect
assay
abil
bind
surfac
menb
cell
bactericid
activ
vitro
seven
protein
high
titr
assay
carri
taken
final
stage
evalu
assess
extent
protein
sequenc
variabl
protein
across
larg
number
menb
isol
largescal
screen
process
two
new
vaccin
candid
emerg
met
criteria
vaccin
candid
phase
clinic
trial
modifi
permiss
ref
macmillan
magazin
ltd
two
sampl
level
singl
base
pair
dna
exampl
compar
genom
sequenc
refer
ame
strain
b
anthraci
ame
isol
first
patient
die
inhal
anthrax
attack
allow
new
polymorph
loci
distinguish
multipl
ame
isol
identifi
sequenc
b
anthraci
strain
well
repres
close
relat
bacillu
cereu
bacillu
thuringiensi
underway
goal
develop
polymorph
databas
b
anthraci
group
provid
import
inform
track
origin
histori
particular
isol
cmf
unpublish
data
technolog
avail
quickli
expand
effort
includ
categori
ac
agent
addit
b
anthraci
genomicsbas
approach
studi
microbi
pathogen
host
profound
impact
way
approach
studi
treatment
infecti
diseas
one
import
challeng
face
us
today
best
exploit
pathogen
immunolog
recogn
although
might
still
bit
earli
fulli
assess
impact
genom
vaccin
develop
estim
avail
genom
sequenc
data
togeth
applic
largescal
approach
reduc
time
requir
identifi
new
vaccin
candid
sever
year
ad
benefit
initi
screen
done
comprehens
way
evalu
potenti
antigen
pathogen
genom
therefor
increas
likelihood
promis
candid
emerg
unfortun
yet
much
progress
use
genomicsbas
approach
develop
vaccin
pathogen
tcellmedi
immun
import
larg
attribut
difficulti
predict
tcell
epitop
protein
sequenc
data
alon
microbi
forens
use
molecular
variat
close
relat
strain
trace
relationship
studi
popul
structur
also
benefit
tremend
avail
compar
genom
data
discrimin
variabl
number
tandem
repeat
vntr
linear
arrang
multipl
copi
short
repeat
dna
sequenc
vari
length
highli
polymorph
make
use
marker
victim
grant
write
one
option
consid
recogn
need
individu
investigatoriniti
research
programm
potenti
bioterror
pathogen
well
larger
comprehens
multiinvestig
research
programm
recent
creat
rce
although
research
programm
focu
develop
new
diagnost
antibiot
vaccin
use
wellproven
method
essenti
fund
initi
reward
innov
think
encourag
incent
project
bioshield
inform
see
onlin
link
box
enabl
us
govern
purchas
vaccin
drug
larg
amount
must
creat
provid
incent
pharmaceut
biotechnolog
industri
rapidli
translat
basic
research
result
new
product
disturb
time
microbi
genom
deliv
hundr
potenti
new
target
antimicrobi
compound
pharmaceut
industri
scale
back
collect
effort
antibiot
develop
profit
margin
suffici
case
key
achiev
research
programm
might
drug
vaccin
stockpil
use
event
emerg
without
continu
sustain
market
new
product
guarante
product
develop
us
govern
must
extend
effort
biodef
arena
becom
full
partner
industri
increas
level
prepared
next
natur
deliber
outbreak
diseas
research
prioriti
learn
anyth
collect
effort
genom
past
sever
year
littl
know
biolog
organ
individu
might
inclin
debat
whether
need
univers
antibiot
antivir
versu
one
organismspecif
potenti
use
vigor
pursu
scienc
underli
research
sound
although
essenti
great
deal
emphasi
place
studi
import
bioterror
agent
b
anthraci
pesti
variola
major
also
import
also
take
broader
view
microbi
world
given
mani
featur
relev
microbi
pathogenesi
share
among
phylogenet
divers
speci
relat
point
need
rememb
collect
focus
great
deal
attent
human
pathogen
social
econom
devast
could
result
attack
virul
plant
anim
pathogen
foot
mouth
diseas
could
much
greater
seen
anthrax
attack
anoth
topic
relev
biodef
research
need
strike
appropri
balanc
share
inform
research
result
bioterror
agent
one
hand
alreadi
seen
provid
inform
downstream
work
crucial
particularli
develop
new
antibiot
vaccin
hand
largescal
technolog
biodef
arena
reason
begin
use
dna
sequenc
analysi
dna
microarray
technolog
collect
inform
natur
variabl
larg
number
isol
import
pathogen
b
anthraci
focu
first
largescal
effort
catalogu
variabl
creat
forens
databas
howev
effort
expand
includ
princip
human
anim
plant
pathogen
effect
track
natur
occur
emerg
infecti
diseas
like
transcriptom
proteom
analys
appli
studi
bioterror
pathogen
quickli
find
subset
gene
role
pathogenesi
hostpathogen
interact
inform
could
potenti
provid
lead
develop
new
antibiot
vaccin
howev
alreadi
shown
inform
might
alway
requir
guarante
success
one
biggest
challeng
us
fact
limit
number
anim
model
system
avail
studi
threaten
bioterror
agent
moreov
clinic
trial
evalu
efficaci
new
antibiot
vaccin
group
infecti
agent
limit
inabl
test
human
subject
would
consid
highli
uneth
deliber
expos
volunt
infecti
agent
natur
outbreak
diseas
rare
nonexist
although
might
tempt
focu
consider
research
effort
small
number
bioterror
agent
much
gain
take
broader
compar
approach
studi
larg
number
pathogen
common
mechan
might
emerg
anthoni
fauci
director
niaid
nih
recent
state
goal
develop
univers
antibiot
antivir
antitoxin
unattain
ref
still
earli
tell
whether
vision
realist
howev
set
tone
infecti
diseas
research
agenda
come
year
although
consensu
larg
infus
us
feder
govern
fund
biodef
research
essenti
ambiti
goal
met
increas
fund
alon
guarante
new
diagnost
antibiot
vaccin
emerg
howev
sever
thing
done
increas
likelihood
success
must
sustain
suffici
commit
fund
enabl
basic
research
begin
today
translat
deliver
achiev
impact
public
health
increas
fund
two
three
year
enough
given
natur
scientif
research
develop
incent
must
creat
attract
suffici
number
outstand
new
investig
infecti
diseas
research
carri
expand
research
agenda
given
natur
scientif
enterpris
creation
longterm
fund
programm
allow
investig
focu
research
avail
mani
countri
around
world
unless
intern
consensu
appropri
way
deal
dualus
data
implement
new
polici
within
unit
state
alon
could
potenti
frustrat
good
scientist
without
increas
overal
level
nation
secur
object
might
easi
achiev
mani
believ
perceiv
threat
pose
kind
inform
univers
agre
scientist
around
globe
clear
genomeen
scienc
central
role
new
biodef
research
agenda
basi
success
far
highli
like
approach
lead
import
new
breakthrough
sever
front
new
biodef
programm
get
underway
vital
import
monitor
progress
set
new
prioriti
dictat
promis
research
result
ultim
unit
state
commit
develop
comprehens
programm
biodef
import
thing
done
ensur
suffici
fund
provid
suffici
period
time
ambiti
goal
new
initi
realiz
success
like
dual
payoff
new
gener
diagnost
antimicrobi
antivir
compound
deliv
protect
citizen
around
world
increas
level
bioprepared
result
could
probabl
also
strong
deterr
futur
deliber
bioterror
attack
concern
individu
malici
intent
could
use
inform
inappropri
risk
pose
potenti
misus
inform
difficult
quantifi
therebi
complic
mani
discuss
januari
sever
scientif
journal
issu
statement
scientif
public
secur
effect
implement
polici
screen
possibl
reject
manuscript
submit
public
editor
conclud
potenti
harm
public
outweigh
societ
benefit
ref
see
also
ref
refer
therein
certainli
import
statement
respons
way
abrog
scientif
investig
respons
area
octob
nation
research
council
nation
academi
scienc
releas
report
entitl
biotechnolog
research
age
terror
contain
new
set
recommend
deal
dualus
research
report
note
need
increas
educ
scientif
commun
dualus
dilemma
institut
biosafeti
committe
review
plan
experi
fall
potenti
area
concern
review
public
potenti
nation
secur
risk
public
stage
creation
nation
scienc
advisori
board
biodefens
resourc
ongo
discuss
scientif
secur
commun
creation
intern
forum
biosecur
promot
discuss
relev
issu
around
world
last
point
perhap
one
import
emerg
report
technolog
could
potenti
misus
